Genome-wide association studies have proven themselves to be powerful tools for discovering the genetic contributions to common diseases, said Elias A. Zerhouni, M.D., director of the NIH, which is part of HHS. Early findings from such studies have identified new genetic variants associated with a higher risk of common diseases such as prostate cancer, diabetes and heart disease, but researchers have only scratched the surface. The genetic studies being funded today will identify many novel genetic variants associated with an increased risk for these health conditions.
The genome-wide association studies will be led by the National Human Genome Research Institute (NHGRI), part of NIH. First-year funding for the studies was contributed by all NIH institutes and centers, including an extra investment by NIHs National Institute of Dental and Craniofacial Research (NIDCR).
The principal investigators, approximate funding levels and health condition to be focused on are:
Terri Beaty, Ph.D., Johns Hopkins University, Baltimore
International Consortium to Identify Genes and Interactions Controlling Oral Clefts,
Laura Bierut, M.D., Washington University School of Medicine, St. Louis
Study of Addiction: Genetics and
|Contact: Geoff Spencer|
NIH/National Human Genome Research Institute